Hydrogen Therapy Reverses Cancer‐Associated Fibroblasts Phenotypes and Remodels Stromal Microenvironment to Stimulate Systematic Anti‐Tumor Immunity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Hydrogen Therapy Reverses Cancer‐Associated Fibroblasts Phenotypes and Remodels Stromal Microenvironment to Stimulate Systematic Anti‐Tumor Immunity ; day:17 ; month:05 ; year:2024 ; extent:15
Advanced science ; (17.05.2024) (gesamt 15)
- Urheber
-
Meng, Xiaoyan
Liu, Zhonglong
Deng, Liang
Yang, Yangzi
Zhu, Yingchun
Sun, Xiaoying
Hao, Yongqiang
He, Yue
Fu, Jingke
- DOI
-
10.1002/advs.202401269
- URN
-
urn:nbn:de:101:1-2405171441553.595970165644
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Meng, Xiaoyan
- Liu, Zhonglong
- Deng, Liang
- Yang, Yangzi
- Zhu, Yingchun
- Sun, Xiaoying
- Hao, Yongqiang
- He, Yue
- Fu, Jingke
Ähnliche Objekte (12)
Biomarkers for cancer-associated fibroblasts
Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts
Targeting of MCL-1 in breast cancer-associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive properties
Activation of STING in pancreatic cancer-associated fibroblasts exerts an antitumor effect by enhancing tumor immunity
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development
Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Advances of cancer-associated fibroblasts in liver cancer
Comparative transcriptome of normal and cancer-associated fibroblasts
SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts
Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities
Biomarkers for cancer-associated fibroblasts
Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts
Targeting of MCL-1 in breast cancer-associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive properties
Activation of STING in pancreatic cancer-associated fibroblasts exerts an antitumor effect by enhancing tumor immunity
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development
Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Advances of cancer-associated fibroblasts in liver cancer
Comparative transcriptome of normal and cancer-associated fibroblasts
SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts
Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities
Biomarkers for cancer-associated fibroblasts
Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts
Targeting of MCL-1 in breast cancer-associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive properties
Activation of STING in pancreatic cancer-associated fibroblasts exerts an antitumor effect by enhancing tumor immunity
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development
Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Advances of cancer-associated fibroblasts in liver cancer
Comparative transcriptome of normal and cancer-associated fibroblasts
SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts